Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Non-small cell lung cancer (NSCLC) (BRAF m)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

2% of NSCLC pts have B-RAF mutation

BRAFV600E mutations occur in 1–2% of lung adenocarcinomas.
Kelly 2018 Expert Review of Anticancer Therapy 18: 1063-1068

These mutations have been associated with poor outcomes and a lower response to platinum-based chemotherapy.
Kelly 2018 Expert Review of Anticancer Therapy 18: 1063-1068…

References (Sources)

Dabrafenib and trametinib for the treatment of non-small cell lung cancer
Kelly 2018 Expert Review of Anticancer Therapy 18: 1063-1068

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Non-small cell lung cancer (NSCLC) (BRAF m)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat